Julien's Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. The thoroughly updated 14th edition features:New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdoseNew research on the use of marijuana to treat Alzheimers, PTSD, and EpilepsyNew coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicityNew research on Cannabidiol (CBD) and its therapeutic usesNew research of the efficacy of antipsychotics to treat dementia, Parkinson's, bipolar, OCD, and PTSDThe use of genetic testing to predict effectiveness of antidepressant treatmentNew research on the use of ketamine for the treatment of depression
Auflage
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für Beruf und Forschung
Für höhere Schule und Studium
Editions-Typ
Illustrationen
Maße
Höhe: 23.5 cm
Breite: 15.5 cm
ISBN-13
978-1-319-24894-9 (9781319248949)
Schweitzer Klassifikation
Claire Advokat received her Ph.D. in physiological psychology from Rutgers University. Her research area is psychopharmacology, specifically drugs used in the treatment of psychiatric and behavioral disorders. She has published over 80 articles, and received funding for her studies from the National Institute of Drug Abuse (NIDA), the Spencer Foundation, the Board of Regents of Louisiana, the State of Louisiana, and the pharmaceutical firm NPS. She received a university teaching award in 2005, served as an ad hoc reviewer for 20 journals, and serves on the editorial board of The Journal of Attention Disorders.
